Moberg Pharma AB (publ) announced the appointment of Shaw Sorooshian as new Vice President and Chief Medical Officer at Moberg Pharma. Shaw Sorooshian will be replacing Kjell Rensfeldt in the management team, bringing extensive experience from his previous position as Senior Director Global Medical Affairs at Sobi AB (Swedish Orphan Biovitrum) as well as preceding senior positions at Shire, Lundbeck and Organon Laboratories. Shaw Sorooshian was born in 1964 and is certified in Pharmaceutical Medicine. Kjell Rensfeldt will be retiring during the fall but will continue to serve as Senior Advisor to Moberg Pharma on a part-time basis.